Alzheimer's disease Trials in Limoges, France
Conditions / Alzheimer's disease / Limoges, France
Research into Alzheimer's disease spans multiple therapeutic approaches and trial phases.
19 total trials for this combination
Showing top 10 of 19 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03114657 | A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD) | TERMINATED | PHASE3 |
| NCT02079246 | Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease | COMPLETED | PHASE3 |
| NCT00490568 | Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers | TERMINATED | PHASE3 |
| NCT00348140 | Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease | COMPLETED | PHASE3 |
| NCT01723826 | A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab | COMPLETED | PHASE2 |
| NCT02051608 | A Study of Gantenerumab in Participants With Mild Alzheimer Disease | COMPLETED | PHASE3 |
| NCT01549834 | Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors | COMPLETED | PHASE2 |
| NCT03036280 | A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Subjects With Early Alzheimer's Disease_ | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT01922258 | Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type | COMPLETED | PHASE3 |
| NCT01343966 | A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY) | COMPLETED | PHASE2 |